Uni-Bio Science - Got Class Ii Medical Device Approval for Recombinant Collagen Dressing
THOMSON REUTERS2024-12-02
Uni-Bio Science - Got Class Ii Medical Device Approval for Recombinant Collagen Dressing
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Australia's S&P/ASX 200 Index Closes up 1.3% at 7,920.5 Points
Fanuc Corp - Plan to Carefully Assess the Impact of Tariffs in the United States and Other Factors, and Promptly Disclose the Forecast Once a Reasonable Calculation Becomes Feasible
Fanuc Corp - Consolidated Financial Forecasts for the Year Ending March 31, 2026 Are Not Reported, as It Is Not Feasible at Present to Reasonably Calculate Them
Fanuc Corp - There Are Numerous Uncertain Factors, Including the Impact of Tariffs in the United States, the Resulting Effects on the Global Economy, Exchange Rate Trends, Geopolitical Risks
Stif France Sas: Portzamparc Raises Target Price to 48.2 EUR From 40.5 EUR ; Rating ‘Buy’